Gain Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/05/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/05/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 14/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$4.7 | −$5.6 | −$5.3 | −$5.8 | −$4.5 | −$4.5 | −$8.1 | −$4 | |
| −$0.11 | −$0.13 | −$0.15 | −$0.19 | −$0.16 | −$0.17 | −$0.42 | −$0.22 | |
| 43 | 42 | 35 | 30 | 29 | 27 | 19 | 18 |
Trend